+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Artificial Tears Market Research and Forecast 2018-2023

  • ID: 4621249
  • Report
  • August 2018
  • Region: Global
  • Orion Market Research Private Limited
until Dec 31st 2021


  • Akorn, Inc.
  • Aura Labs Ltd.
  • Essilor International S.A
  • Merck & Co., Inc.
  • Novartis International Ag
  • Sanofi S.A.
  • MORE
The Artificial tears market is expected to grow significantly during the forecast period (2018-2023). Artificial tears lubricate the ocular surface reduce tear osmolarity and protect the ocular surface from desiccation. The market is growing due to the impact of some factors such as growing dry eye syndrome (DES) coupled with geriatric population. As aging results in weaker eyesight, people are more at risk of ophthalmic disorders such as dry eye syndrome.

The rising use of contact lenses, digital workloads, and innovation in the product creates future opportunities for the growth of the market. However, there are some factors that act as barriers for the growth of the market such as side effects of the artificial tears and lack of the awareness among people across the globe.

Global artificial tears market is segmented on the basis of types, delivery method and application. On the basis of types, the market is further diversified as cellulose derived tears, glycerin derived tears, oil-based emulsion tears and polyethylene glycol and propylene glycol-based tears. Based on the delivery method, the market is bifurcated as eye drops and ointments. According to the application, the market is further subdivided as dry eyes treatment and contact lenses moisture. Among all the types, glycerin derived tears segment is expected to hold the major share owing to its capability of keeping eyes moist for long time.

Considering the regional outlook market is divided into North America, Europe, Asia Pacific and Rest of the world. Asia Pacific creates more growth opportunities due to an increase in geriatric population and rising incidences of DES. North America and Europe covers the significant market share with their ability of advanced technology, innovation in the products and awareness among people.

The companies contributing in the global market consists of Akron Inc., Allergan plc, Novartis International AG, Johnson & Johnson, Ocusoft Inc., Aura lab Ltd., and Carl Zeiss AG.

Research Methodology:

The market study of artificial tears market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.

Secondary sources include:
  • Financial reports of companies involved in the market
  • Authentic Public Databases such as American Optometric Association, American Academy of Ophthalmology and others.
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalogue
The report is intended for drug manufacturers, healthcare provider, government organizations for overall market analysis, and competitive analysis. The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers and initial norms. The report will serve as a source for delivering insights into the market for better business decisions.

Market Segmentation:

Global Artificial tears market is segmented on the basis of regional outlook and following segments:
1. Global Artificial tears Market Research and Analysis, By Type
2. Global Artificial tears Market Research and Analysis, By Delivery Method
3. Global Artificial tears Market Research and Analysis, By Application
4. Global Artificial tears Market Research and Analysis, By Region

The Report Covers
  • Comprehensive research methodology of global artificial tears
  • This report also includes detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global artificial tears market.
  • Insights about market determinants which are stimulating the global artificial tears market.
Note: Product cover images may vary from those shown


  • Akorn, Inc.
  • Aura Labs Ltd.
  • Essilor International S.A
  • Merck & Co., Inc.
  • Novartis International Ag
  • Sanofi S.A.
  • MORE
1. Report Summary
1.1. Research Methods And Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview And Insights
2.1. Definition
2.2. Analyst Insights &Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulations
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India
2.3.5. Rest Of The World

3. Market Determinant
3.1. Motivators
3.1.1. Growing Cases Of Dry Eye Syndrome (Des)
3.1.2. Rising Requirement Of Advanced Surgeries
3.1.3. Growing Use Of Mobile Phones And Computers
3.1.4. Rising Use Of Contact Lenses
3.2. Restraints
3.2.1. Side Effects Of Artificial Tears
3.2.2. Lack Of Awareness Among People
3.3. Opportunities
3.3.1. Innovation In The Product
3.3.2. Growing Demand For Preservative Free Artificial Tears

4. Market Segmentation
4.1. By Type
4.1.1. Cellulose Derived Tears
4.1.2. Glycerine Derived Tears
4.1.3. Oil Based Emulsion Tears
4.1.4. Polyethylene Glycol And Propylene Glycol-Based Tears
4.2. By Delivery Method
4.2.1. Eye Drops
4.2.2. Ointments
4.3. By Application
4.3.1. Dry Eyes Treatment
4.3.2. Contact Lenses Moisture

5. Competitive Landscape
5.1. Key Market Strategies
5.2. Key Company Analysis

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.1.3. Rest Of North America
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest Of Europe
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.4. Rest Of The World

7. Company Profiles
7.1. Abbott Medical Optics Inc.
7.2. Akorn, Inc.
7.3. Alcon Laboratories, Inc.
7.4. Allergan Plc
7.5. Aura Labs Ltd.
7.6. Bausch & Lomb Incorporation
7.7. Bayer Ag
7.8. Carl Zeiss Ag
7.9. Essilor International S.A
7.10. Hoya Corporation
7.11. Johnson & Johnson
7.12. Merck & Co., Inc.
7.13. Nicox S.A
7.14. Novagali Pharma S.A.
7.15. Novartis International Ag
7.16. Ocusoft, Inc.
7.17. Pfizer, Inc.
7.18. Rohto Pharmaceutical Co., Ltd.
7.19. Sanofi S.A.
7.20. Santen Pharmaceuticals Co., Ltd.
7.21. Similasan Corporation
7.22. Teva Pharmaceuticals Industries, Ltd.
7.23. Topcon Corporation
7.24. Ursapharm Arzneimittel Gmbh
7.25. Valeant Pharmaceuticals International, Inc.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Medical Optics Inc.
  • Akorn, Inc.
  • Alcon Laboratories, Inc.
  • Allergan Plc
  • Aura Labs Ltd.
  • Bausch & Lomb Incorporation
  • Bayer Ag
  • Carl Zeiss Ag
  • Essilor International S.A
  • Hoya Corporation
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Nicox S.A
  • Novagali Pharma S.A.
  • Novartis International Ag
  • Ocusoft, Inc.
  • Pfizer, Inc.
  • Rohto Pharmaceutical Co., Ltd.
  • Sanofi S.A.
  • Santen Pharmaceuticals Co., Ltd.
  • Similasan Corporation
  • Teva Pharmaceuticals Industries, Ltd.
  • Topcon Corporation
  • Ursapharm Arzneimittel Gmbh
  • Valeant Pharmaceuticals International, Inc.
Note: Product cover images may vary from those shown